Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 28 entries
View as:

Study to Evaluate the Efficacy and Safety of Genexol-PM Once a Week for Gynecologic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02739529 Org: User:
Start: 04/30/16 End: 03/31/18 Due: 03/31/19

A Study in Adults Evaluating Polycaprolactone Microsphere Filler for Treatment of Moderate to Severe Nasolabial Folds

Phase: N/A Priority: Normal
NCT ID: NCT06961448 Org: User:
Start: 05/01/25 End: 11/01/26 Due: 11/01/27

A Pilot Study to Investigate the Efficacy of Partially Absorbable Mesh in Patients With Pelvic Organ Prolapsed

Phase: N/A Priority: Normal
NCT ID: NCT02320643 Org: User:
Start: 12/31/14 End: 04/30/17 Due: 04/30/18

Relative Bioavailability Study of Lipidil® Supra (Fenofibrate 160mg) Versus SYO-0805 (Fenofibrate 65mg)

Phase: N/A Priority: Normal
NCT ID: NCT01353404 Org: User:
Start: 06/30/11 End: 08/31/11 Due: 08/31/12

Clinical Trial to Evaluate the Safety and Efficacy of MONOFIX® PGCL Suture in Laparoscopic Surgery

Phase: N/A Priority: Normal
NCT ID: NCT05645809 Org: User:
Start: 11/03/22 End: 09/30/23 Due: 09/30/24

Study to Compare Pharmacokinetic Property of SYO-1644 Tab. and Nexavar Tab. in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT03674060 Org: User:
Start: 10/28/18 End: 07/23/19 Due: 07/23/20

Trial to Determine the Maximum Tolerated Dose of Genexol-PM Plus Gemcitabine and Evaluate Efficacy and Safety of Genexol-PM Regimens in Subjects With Advanced Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00882973 Org: User:
Start: 09/30/08 End: 11/30/10 Due: 11/30/11

Crossover Study to Compare Pharmacokinetic Property of SYO-1126 and Glivec Film Coated Tab in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01504984 Org: User:
Start: 03/31/12 End: 04/30/12 Due: 04/30/13

Pharmacokinetic Study of Docetaxel-PNP and Taxotere to Treat Patient With Advanced Solid Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02274610 Org: User:
Start: 11/30/14 End: 12/31/15 Due: 12/31/16

Compare the Efficacy and the Safety of Taxotere and Nanoxel M as Neoadjuvant Chemotherapy in Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05207514 Org: User:
Start: 03/31/22 End: 05/09/24 Due: 05/09/25

Determine MTD, Evaluate Efficacy and Safety of Genexol®-PM Plus Carboplatin With Advanced Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00877253 Org: User:
Start: 05/31/08 End: 06/30/09 Due: 06/30/10

Evaluate the Efficacy and Safety of Genexol®-PM Compared to Genexol® in Recurrent or Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00876486 Org: User:
Start: 12/31/08 End: 11/30/13 Due: 11/30/14

A Trial to Determine the Maximum Tolerated Dose and Evaluate the Safety and Pharmacokinetics of Docetaxel-PNP, Polymeric Nanoparticle Formulation of Docetaxel, in Subjects With Advanced Solid Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT01103791 Org: User:
Start: 04/30/10 End: 04/30/12 Due: 04/30/13

A Study Comparing DMSB01 and Rejuran® for Temporary Crow's Feet Lines Improvement

Phase: N/A Priority: Normal
NCT ID: NCT06402058 Org: User:
Start: 06/10/24 End: 04/30/25 Due: 04/30/26

Study to Evaluate the Safety of Nanoxel M Inj.

Phase: N/A Priority: Normal
NCT ID: NCT04066335 Org: User:
Start: 09/18/19 End: 08/31/24 Due: 08/31/25

Study to Evaluate the Pharmacokinetic Properties of SYP-1018 (Voriconazole-loaded PNP) and Voriconazole (Vfend)

Phase: N/A Priority: Normal
NCT ID: NCT01657201 Org: User:
Start: 09/30/12 End: 11/30/12 Due: 11/30/13

A Study Comparing SYB PDO Thread and MINT Lift® for Temporary Nasolabial Fold Improvement

Phase: N/A Priority: Normal
NCT ID: NCT06093321 Org: User:
Start: 11/13/23 End: 02/28/25 Due: 02/28/26

Study to Evaluate the Efficacy and Safety Of Intravesical Nanoxel®M In BCG Refractory NMIBC

Phase: N/A Priority: Normal
NCT ID: NCT02982395 Org: User:
Start: 01/31/17 End: 08/31/18 Due: 08/31/19

Study to Evaluate the Efficacy and Safety of Docetaxel Polymeric Micelle (PM) in Recurrent or Metastatic HNSCC

Phase: N/A Priority: Normal
NCT ID: NCT02639858 Org: User:
Start: 10/31/15 End: 09/30/20 Due: 09/30/21

A Trial of Paclitaxel (Genexol®) and Cisplatin Versus Paclitaxel Loaded Polymeric Micelle (Genexol-PM®) and Cisplatin in Advanced Non Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01023347 Org: User:
Start: 06/30/08 End: 06/30/12 Due: 06/30/13

Study of Weekly Genexol®-PM Plus Gemcitabine in Subjects With Recurrent and Metastatic Adenocarcinoma of the Pancreas

Phase: N/A Priority: Normal
NCT ID: NCT02739633 Org: User:
Start: 04/30/16 End: 12/31/19 Due: 12/31/20

A Trial to Evaluate Efficacy and Safety of the Combination Therapy of Genexol®-PM Plus Carboplatin® Compared to Genexol® Plus Carboplatin® as a Firstline Treatment in Subjects With Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01276548 Org: User:
Start: 10/31/09 End: 09/30/12 Due: 09/30/13

A Study to Evaluate the Safety and Efficacy of SYB Filler(SF-01) in the Correction of Nasolabial Folds

Phase: N/A Priority: Normal
NCT ID: NCT03932045 Org: User:
Start: 10/08/18 End: 08/12/22 Due: 08/12/23

Crossover Study to Compare Pharmacokinetic Property of SYP-1512 Tab and Revlimid Cap in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT03208218 Org: User:
Start: 08/17/16 End: 10/31/16 Due: 10/31/17

Comparative Study of Safety and Efficacy of Heavyweight and Partially Absorbable Mesh in Inguinal Hernia Repair

Phase: N/A Priority: Normal
NCT ID: NCT01877122 Org: User:
Start: 04/30/13 End: 12/31/14 Due: 12/31/15